C&R Research Inc. (KOSDAQ:359090)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019
Biotechnology		55.10B	48.47B	43.17B	-
Biotechnology Growth		13.68%	12.28%	-	-
Sale of Goods		-	-	-	622.00K
Other		-	-	-	106.76M
Provision of Services		-	-	-	27.10B
Total		55.10B	48.47B	43.17B	27.20B
Total Growth		13.68%	12.28%	58.70%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019
South Korea		54.84B	47.42B	43.10B	27.06B
South Korea Growth		15.63%	10.03%	59.28%	-
Overseas		264.83M	1.08B	71.94M	144.44M
Overseas Growth		-75.38%	1395.16%	-50.19%	-
Total		55.10B	48.50B	43.17B	27.20B
Total Growth		13.62%	12.34%	58.70%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 21, 2026

Data Sources Report a data error